3 results
Approved WMOCompleted
To compare the effect of semaglutide 1.0 mg once-weekly versus exenatide extended release (ER) 2.0 mg once-weekly on glycaemic control after 56 weeks of treatment.
Approved WMOWill not start
Using a single formulation of PfPEBS LSP administered at two different doses, one of 5*g and the other one of 30*g, both adjuvanted with aluminium hydroxide, in two immunizations at 28 days interval, to evaluate a) the safety and immunogenicity (…
Approved WMORecruiting
The primary objective of this study is to assess the improvement in clinical outcome of rTSA with Glenius one year after surgery. The secondary objectives are to gather patient-reported clinical outcomes, radiological outcomes (implant position/…